Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 2Pancreatic Ductal Adenocarcinoma 1Neoplasms 1Motor Activity 1Biliary Tract Neoplasms 1Advanced Solid Neoplasms 1

Interventions

olaparib 1mitazalimab 1TAK-659 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Solid Neoplasms × mitazalimab × Clear all
NCT02829099 2022-10-06

A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors

Janssen Research & Development, LLC

Phase 1 Completed
95 enrolled

Advanced Solid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡